Kara Gessinger

Kara Gessinger is a Senior Clinical Specialist in Oncology at Puma Biotechnology, Inc., where responsibilities include promoting oral therapy for HER2+ Breast cancer and facilitating a successful LOA contract that increased sales by 30% at Parkview Cancer Institute in 2023. Previously, at AMAG Pharmaceuticals, Gessinger served as a Specialty Account Manager, achieving a top 15% ranking and successfully launching Vyleesi, while at Shionogi Inc., Gessinger held roles that focused on sales force effectiveness and training, consistently ranking in the top 20% for sales. Early career experience includes account executive positions at ABC57 and Fox28 WSJV TV, recognized for top billing sales and new business development. Gessinger holds a Bachelor of Business Administration in Marketing and Business Management from Western Michigan University.